Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
4152-A UNVEILING RACIAL DISCREPANCIES IN THE OUTCOMES OF PORTAL VEIN THROMBOSIS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA - A 5-YEAR NATIONWIDE ANALYSIS Fnu Vikash 1 , Sindhu Vikash 1 , Yassine Kilani 2 , Vikash Kumar 3 , Noor Syed 4 , Sobaan Taj 5 , Abu Abbasi 6 , Syeda Ashna Fatima Kamal 7 , Dushyant Dahiya 8 and Sunny Patel 1 , (1)Jacobi Medical Center/Albert Einstein College of Medicine, (2)Lincoln Medical Center, (3)The Brooklyn Hospital Center, (4)Santa Clara Valley Medical Center, (5)Hackensack Meridian Jersey Shore University Medical Center, (6)Loyola University Medical Center, Chicago, IL, (7)Southern Illinois University (SIU)), (8)The University of Kansas School of Medicine Background: Portal vein thrombosis (PVT) is considered a negative prognostic factor in hepatocellular carcinoma (HCC) patients
2025 Jan 1;21(2):725-744
Tesamorelin vs Sermorelin in International Studies Research interest in GHRH analogs has expanded significantly across North America, Europe, and Asia-Pacific research institutions over the past three years
In fact, B cells are increased in TDLNs and they produce pathogenic IgG that interacts with heat shock protein family A member 4 (HSPA4), activating the NF-B pathway that mediates the activation of the CXCR4/SDF1 axis (188)
US$ 27.20
US$ 28.75
US$ 23.29
US$ 26.73
US$ 28.79
